Physician profile
Gareth J Morgan
NPI 1245783349
$536,364.66
in general payments reported to CMS, 2019-2025
22 companies · $80K in 2025
The $80K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $28K · 2021: $64K · 2022: $108K · 2023: $112K · 2024: $116K · 2025: $80K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $218K · Travel and Lodging: $42K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $218,032.50 |
| Travel and Lodging | $42,005.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,162.50 |
| Food and Beverage | $12,066.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Numed For Children, LLC | $161,702.37 | 2021-2025 | |
| Edwards Lifesciences Corporation | $140,227.83 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| B. Braun Interventional Systems INC. | $85,675.97 | 2019-2025 | Cp Stent, Nit-Occlud Pda, Occlutech Pistol Pusher |
| W. L. Gore & Associates, INC. | $48,859.17 | 2019-2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $37,161.29 | 2021-2025 | Harmony, Concertotm, Corevalve Evolut R |
| Occlutech US LLC | $14,159.02 | 2025 | |
| Medtronic Vascular, INC. | $13,160.27 | 2019-2020 | |
| Abbott Laboratories | $11,886.32 | 2019-2025 | Amplatzer, Amplatzer Piccolo, Dragonfly Opstar |
| Celgene Corporation | $10,576.09 | 2020 | |
| Penumbra, INC. | $9,986.03 | 2022-2025 | Indigo System, Ruby Coil |
| Omega Medical Imaging, LLC | $856.48 | 2023 | |
| Stemline Therapeutics INC. | $576.72 | 2020-2021 | |
| Galt Medical | $488.49 | 2019 | |
| Philips North America LLC | $251.36 | 2019-2022 | |
| Terumo Medical Corporation | $181.57 | 2022-2024 | Glidesheath Slender, Azur Cx Detachable, Progreat |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aero US INC | $169.89 | 2023 | Aerogen Solo Nebulizer System, Aerogen Solo; Aerogen Ultra, Aerogen Usb Controller System |
| Balt USA, LLC | $156.14 | 2024 | Prestige Coil System |
| Asahi Intecc USA, INC. | $122.85 | 2022 | |
| Abiomed | $98.18 | 2023-2025 | Impella |
| Renata Medical, INC. | $41.72 | 2025 | Minima Stent System - 8mm, Minima Stent System - 6mm |
| Argon Medical Devices, INC. | $14.93 | 2022 | |
| Biosense Webster, INC. | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gareth Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.